Skip to content

Transcranial Magnetic Stimulation in the treatment of major depression in cancer

Transcranial Magnetic Stimulation in the treatment of major depression in cancer - Transcranial Magnetic Stimulation in the treatment of major depression in cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000004457
Enrollment
20
Registered
2010-10-27
Start date
2011-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depression

Interventions

TMS are performed with a frequency of 10Hz, trains of 6s, inter-train-intervals of 60s, 15 trains per session, 2 sessions per day on 10 working days.

Sponsors

Reserch Center for Innovative Oncology National Cancer Center Hospital East
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients: 1)are now under treatment in National Cancer Center Hospital East 2)are at least 20 years old and over 3)have a moderate or severe major and minor depressive episode meeting DSM-4 criteria 4)are not able to take antidepressants

Exclusion criteria

Exclusion criteria: Patients: 1)who is not able to understand this study because of dementia, delirium, or other cognitive disorder 2)have brain metastasis 3)have neurological illness (e.g. epilepsy, meningitis) 4)had a history of convulsions 5)have a risk of epilepsy checked by the EEG 6)had previous neurosurgery with implants of metal 7)have pacemaker 8)attempt suicide or have the idea of suicide 9)fall into a stupor 10)have psychotic depression 11)had a history of failed response to electroconvulsive therapy 12)are depressed by organic illness or medication

Design outcomes

Primary

MeasureTime frame
HAM-D

Secondary

MeasureTime frame
MADRS,VAS,CGI

Countries

Japan

Contacts

Public ContactAsao Ogawa

Reserch Center for Innovative Oncology National Cancer Center Hospital East Psycho Oncology Division

asogawa@east.ncc.go.jp04-7134-7013

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026